Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Delivery of radiotherapy in the DBCG 82 b&c trials analyzed
December 29th, 2005
Researchers audited if delivery of radiotherapy in the DBCG 82 b&c trials complied with guidelines. "In the DBCG 82 b&c trials, 3083 patients with stages II and III breast cancer were randomized to receive postmastectomy radiotherapy (RT) versus no RT in addition to systemic therapy. The study showed a decrease in locoregional recurrences and an improved survival in patients receiving RT," scientists in Denmark reported. "The aim of the present study was to describe the delivered RT for the 1538 patients who were randomized to RT, and to evaluate the compliance with the RT guidelines. Basic information about the given RT was recorded in the DBCG...
Source: Women's Health Weekly (2005-12-29)
|
